Infinity Pharmaceuticals completes its wind-down after bankruptcy. Creditors are being paid first, leaving shareholders with minimal to no expected payout as the company dissolves.
For investors holding shares of Infinity Pharmaceuticals, the journey is reaching its definitive conclusion. The company has entered the final stage of its corporate wind-down following a bankruptcy filing and the subsequent sale of nearly all its assets. The central question now is what, if anything, will ultimately be distributed to its equity holders.
From Failed Merger to Chapter 11
The path to liquidation was paved by a collapsed merger attempt and severe financial constraints. The company initiated Chapter 11 bankruptcy proceedings in…